PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Metformin ameliorates bile duct ligation-induced acute hepatic injury via regulation of ER stress.

Mouse / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31791444 ↗2020Reported benefit

Metformin ameliorates bile duct ligation-induced acute hepatic injury via regulation of ER stress.

MouseOtherC57BL/6maleIntraperitoneal or oral gavage200 mg/kg/day

Model: Bile duct ligation, the common bile duct ligated twice with 5-0 silk and cut between the ligatures, with harvest 3 days later; in vitro glycochenodeoxycholic acid treatment of primary hepatocytes

Metformin reduced bile duct ligation induced hepatic necrosis, neutrophil infiltration, necroptosis markers, chemokines and circulating TNF-alpha alongside suppressed endoplasmic reticulum stress markers, with matching protection in primary hepatocytes.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.